That differences in IL-37 gene polymorphisms in combination with behavioral or other specific patient-related factors may differently direct phenotypic variability was demonstrated in a recent epidemiologic study, where authors searched for IL-37 gene polymorphisms in individuals with and without hypercholesterolemia [21]. This evidence concerns the gene IL37 and familial hypercholesterolemia.